Company intelligence / Profile preview

Smart Meter

Tampa, Florida, United Statessmartmetertexas.com ↗

Ownership: Private
Development stage: Commercial

Overview

Smart Meter’s cellular-enabled devices—including blood glucose meters (iGlucose), blood pressure monitors (iBloodPressure Classic Multi Cuff Monitor), pulse oximeters and weight scales—are FDA-cleared and CE-marked. They are used in commercial remote patient monitoring programs across the US and Europe. Clinical studies have shown benefits in diabetes management and hypertension control using these devices[6][7].

Therapeutic areas: PulmonologyMetabolic DisordersEndocrinologyCardiovascularInfectious Diseases
Modalities: Device
Industry: Physiological Monitoring

Partnerships

AT&T (exclusive private data network for device connectivity)Lark Health (digital diabetes management collaboration)Validic Inc. (integration into digital health IoT platform)

Beyond the preview

Go deeper on Smart Meter.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Smart Meter.

Explore the full profile